Emerging as a promising advance in the struggle against obesity, this medication is capturing considerable attention . This treatment combines the action of two recognized GLP-1 receptor agonists, dulaglutide , and an unique glucose-dependent peptide component. Preliminary study data have demonstrated substantial body loss in individuals with exces